Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Jan;67(783):23–32. doi: 10.1136/pgmj.67.783.23

Endocrinology.

M A Baxter 1, M C Sheppard 1
PMCID: PMC2398948  PMID: 2057422

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med. 1989 Nov 16;321(20):1349–1352. doi: 10.1056/NEJM198911163212001. [DOI] [PubMed] [Google Scholar]
  2. Cooper D. S. Thyroid hormone and the skeleton: a bone of contention. JAMA. 1988 Jun 3;259(21):3175–3175. [PubMed] [Google Scholar]
  3. Crist D. M., Peake G. T., Egan P. A., Waters D. L. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol (1985) 1988 Aug;65(2):579–584. doi: 10.1152/jappl.1988.65.2.579. [DOI] [PubMed] [Google Scholar]
  4. Fleck B. W., Toft A. D. Graves' ophthalmopathy. BMJ. 1990 May 26;300(6736):1352–1353. doi: 10.1136/bmj.300.6736.1352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Franklyn J. A., Sheppard M. C. Hormonal control of gene expression. Clin Endocrinol (Oxf) 1988 Sep;29(3):337–348. doi: 10.1111/j.1365-2265.1988.tb01232.x. [DOI] [PubMed] [Google Scholar]
  6. Franklyn J. A., Sheppard M. C. Thyroxine replacement treatment and osteoporosis. BMJ. 1990 Mar 17;300(6726):693–694. doi: 10.1136/bmj.300.6726.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gwinup G., Elias A. N., Ascher M. S. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA. 1982 Apr 16;247(15):2135–2138. [PubMed] [Google Scholar]
  8. Homburg R., Eshel A., Abdalla H. I., Jacobs H. S. Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf) 1988 Jul;29(1):113–117. doi: 10.1111/j.1365-2265.1988.tb00252.x. [DOI] [PubMed] [Google Scholar]
  9. Homburg R., West C., Torresani T., Jacobs H. S. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil Steril. 1990 Feb;53(2):254–260. doi: 10.1016/s0015-0282(16)53277-4. [DOI] [PubMed] [Google Scholar]
  10. Hughes D. E., MacDonald B. R., Russell R. G., Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest. 1989 Jun;83(6):1930–1935. doi: 10.1172/JCI114100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jørgensen J. O., Pedersen S. A., Thuesen L., Jørgensen J., Ingemann-Hansen T., Skakkebaek N. E., Christiansen J. S. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989 Jun 3;1(8649):1221–1225. doi: 10.1016/s0140-6736(89)92328-3. [DOI] [PubMed] [Google Scholar]
  12. Kendall-Taylor P., Crombie A. L., Stephenson A. M., Hardwick M., Hall K. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ. 1988 Dec 17;297(6663):1574–1578. doi: 10.1136/bmj.297.6663.1574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koenig R. J., Lazar M. A., Hodin R. A., Brent G. A., Larsen P. R., Chin W. W., Moore D. D. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature. 1989 Feb 16;337(6208):659–661. doi: 10.1038/337659a0. [DOI] [PubMed] [Google Scholar]
  14. Paul T. L., Kerrigan J., Kelly A. M., Braverman L. E., Baran D. T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988 Jun 3;259(21):3137–3141. [PubMed] [Google Scholar]
  15. Prummel M. F., Mourits M. P., Berghout A., Krenning E. P., van der Gaag R., Koornneef L., Wiersinga W. M. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med. 1989 Nov 16;321(20):1353–1359. doi: 10.1056/NEJM198911163212002. [DOI] [PubMed] [Google Scholar]
  16. Ralston S. H., Gallacher S. J., Patel U., Dryburgh F. J., Fraser W. D., Cowan R. A., Boyle I. T. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet. 1989 Nov 18;2(8673):1180–1182. doi: 10.1016/s0140-6736(89)91791-1. [DOI] [PubMed] [Google Scholar]
  17. Ribot C., Tremollieres F., Pouilles J. M., Louvet J. P. Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 1990 Aug;33(2):143–153. doi: 10.1111/j.1365-2265.1990.tb00477.x. [DOI] [PubMed] [Google Scholar]
  18. Riggs B. L. A new option for treating osteoporosis. N Engl J Med. 1990 Jul 12;323(2):124–125. doi: 10.1056/NEJM199007123230209. [DOI] [PubMed] [Google Scholar]
  19. Rosenfeld R. G. Update on growth hormone therapy for Turner's syndrome. Acta Paediatr Scand Suppl. 1989;356:103–110. doi: 10.1111/j.1651-2227.1989.tb11258.x. [DOI] [PubMed] [Google Scholar]
  20. Ross D. S., Neer R. M., Ridgway E. C., Daniels G. H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 1987 Jun;82(6):1167–1170. doi: 10.1016/0002-9343(87)90219-1. [DOI] [PubMed] [Google Scholar]
  21. Sakurai A., Takeda K., Ain K., Ceccarelli P., Nakai A., Seino S., Bell G. I., Refetoff S., DeGroot L. J. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977–8981. doi: 10.1073/pnas.86.22.8977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Salomon F., Cuneo R. C., Hesp R., Sönksen P. H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989 Dec 28;321(26):1797–1803. doi: 10.1056/NEJM198912283212605. [DOI] [PubMed] [Google Scholar]
  23. Sarne D. H., Sobieszczyk S., Ain K. B., Refetoff S. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression. J Clin Endocrinol Metab. 1990 May;70(5):1305–1311. doi: 10.1210/jcem-70-5-1305. [DOI] [PubMed] [Google Scholar]
  24. Sawin C. T., Geller A., Hershman J. M., Castelli W., Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA. 1989 May 12;261(18):2653–2655. doi: 10.1001/jama.261.18.2653. [DOI] [PubMed] [Google Scholar]
  25. Shine B., Fells P., Edwards O. M., Weetman A. P. Association between Graves' ophthalmopathy and smoking. Lancet. 1990 May 26;335(8700):1261–1263. doi: 10.1016/0140-6736(90)91315-2. [DOI] [PubMed] [Google Scholar]
  26. Solomon B., Glinoer D., Lagasse R., Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab. 1990 Jun;70(6):1518–1524. doi: 10.1210/jcem-70-6-1518. [DOI] [PubMed] [Google Scholar]
  27. Sridama V., DeGroot L. J. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med. 1989 Jul;87(1):70–73. doi: 10.1016/s0002-9343(89)80485-1. [DOI] [PubMed] [Google Scholar]
  28. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
  29. Taelman P., Kaufman J. M., Janssens X., Vandecauter H., Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol (Oxf) 1990 Jul;33(1):107–117. doi: 10.1111/j.1365-2265.1990.tb00471.x. [DOI] [PubMed] [Google Scholar]
  30. Toh S. H., Brown P. H. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J Bone Miner Res. 1990 May;5(5):463–467. doi: 10.1002/jbmr.5650050507. [DOI] [PubMed] [Google Scholar]
  31. Usala S. J., Bale A. E., Gesundheit N., Weinberger C., Lash R. W., Wondisford F. E., McBride O. W., Weintraub B. D. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol. 1988 Dec;2(12):1217–1220. doi: 10.1210/mend-2-12-1217. [DOI] [PubMed] [Google Scholar]
  32. Usala S. J., Tennyson G. E., Bale A. E., Lash R. W., Gesundheit N., Wondisford F. E., Accili D., Hauser P., Weintraub B. D. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest. 1990 Jan;85(1):93–100. doi: 10.1172/JCI114438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Volpe A., Coukos G., Artini P. G., Silferi M., Petraglia F., Boghen M., D'Ambrogio G. D., Genazzani A. R. Pregnancy following combined growth hormone--pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea. Hum Reprod. 1990 Apr;5(3):345–347. doi: 10.1093/oxfordjournals.humrep.a137102. [DOI] [PubMed] [Google Scholar]
  34. Watts N. B., Harris S. T., Genant H. K., Wasnich R. D., Miller P. D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. doi: 10.1056/NEJM199007123230201. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES